Zifo, a company offering specialized IT services tailored for the life sciences sector, is gearing up to broaden its operations in Chennai. With a target revenue of ₹1,000 crore by the end of the current fiscal year on March 31, 2024, the company has sustained an impressive growth rate of approximately 30% in recent years, as highlighted by the brands MD and CEO, Raj Prakash.
Established in 2008 with a primary focus on delivering specialized IT solutions for clinical trial applications, Zifo has since diversified its portfolio to emerge as a comprehensive clinical biometrics service provider. Furthermore, it has extended its services into research and lab information domains. Zifo’s offerings encompass scientific information services spanning R&D, manufacturing, and clinical sectors within industries such as pharmaceuticals, biotechnology, and chemicals.
As reported by businessline, the company’s spectrum of services includes comprehensive scientific informatics solutions, ranging from business analysis to program and project management and validation. Zifo plays a pivotal role in facilitating the digital transformation of critical processes including drug discovery, clinical development, manufacturing quality control, and genomics across diverse industries such as pharmaceuticals, biotechnology, medical devices, and process engineering.
